Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing obese population, increasing government initiatives for healthcare infrastructure, and development of combination therapies.
The anorexiants market is segmented as below:
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the anorexiants market covers the following areas:
- Anorexiants market sizing
- Anorexiants market forecast
- Anorexiants market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
The following companies are recognized as the key players in the global anorexiants market: Bausch Health Companies Inc., Currax Pharmaceuticals LLC, Elite Pharmaceuticals Inc., Epic Pharma LLC, F. Hoffmann La Roche Ltd., Hi Tech Pharmaceuticals, Intas Pharmaceuticals Ltd., Johnson and Johnson Services Inc., KVK Tech Inc., Lannett Co. Inc., Novartis AG, Novo Nordisk AS, Pfizer Inc., Recordati S.p.A, Searchlight Pharma Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Virtus Nutrition LLC, VIVUS LLC, and Zydus Lifesciences Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is research and approval of new drugs."
According to the report, one of the major drivers for this market is the growing obese population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bausch Health Companies Inc.
- Currax Pharmaceuticals LLC
- Elite Pharmaceuticals Inc.
- Epic Pharma LLC
- F. Hoffmann La Roche Ltd.
- Hi Tech Pharmaceuticals
- Intas Pharmaceuticals Ltd.
- Johnson and Johnson Services Inc.
- KVK Tech Inc.
- Lannett Co. Inc.
- Novartis AG
- Novo Nordisk AS
- Pfizer Inc.
- Recordati S.p.A
- Searchlight Pharma Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Virtus Nutrition LLC
- VIVUS LLC
- Zydus Lifesciences Ltd.